{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:36Z","timestamp":1794473376152,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,4]]},"abstract":"<jats:p>Following percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is key to preventing thrombosis. However, the use of DAPT is strongly associated with an increased risk of Gastrointestinal Bleeding, which not only affects patient recovery but also increases the healthcare burden. This study aims to determine the influence of past medical history and factors during hospitalization on the development of postoperative GIB in patients undergoing PCI with DAPT. A total of 380 patients were collected in this study. A total of 42 patients developed GIB during the 1-year follow-up period. Preoperative and postoperative clinical data and past medical history of patients were collected to study the correlates affecting the occurrence of GIB in the postoperative period in patients undergoing PCI with DAPT and to establish a prediction model. Single-factor logistic regression analysis showed: gender, age, past history of bleeding, past history of cancer or tumor, smoking history, history of heart failure, history of PPI use, renal insufficiency, and hypoproteinemia are potential risk factors that may influence the occurrence of GIB postoperatively in patients undergoing DAPT for PCI, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.2. The data obtained were further included in multi-factor logistic regression analysis: gender (female), past history of bleeding, past history of cancer or tumor, smoking history, heart failure, renal insufficiency were independent risk factors influencing the occurrence of GIB postoperatively in PCI patients undergoing DAPT, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05. The findings of this study confirm that gender (female), past history of bleeding, past history of cancer or tumor, smoking history, heart failure and renal insufficiency are independent risk factors for the development of GIB postoperatively in PCI patients undergoing DAPT.<\/jats:p>","DOI":"10.1097\/md.0000000000041935","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:01:03Z","timestamp":1744804863000},"page":"e41935","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of risk factors for gastrointestinal bleeding in percutaneous coronary intervention patients treated with dual antiplatelet therapy after surgery"],"prefix":"10.1097","volume":"104","author":[{"given":"Caiping","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hangzhou Cancer Hospital, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Cancer Hospital, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8675-1875","authenticated-orcid":false,"given":"Renya","family":"Shuai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Cancer Hospital, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250416","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20250416","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"R3-20250416","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2016.11.003","article-title":"Comparison of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary artery disease.","volume":"119","author":"Naqvi","year":"2017","journal-title":"Am J Cardiol"},{"key":"R4-20250416","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCULATIONAHA.122.062714","article-title":"Survival after invasive or conservative management of stable coronary disease.","volume":"147","author":"Hochman","year":"2023","journal-title":"Circulation"},{"key":"R5-20250416","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jacc.2023.07.031","article-title":"Comparison of antiplatelet monotherapies after percutaneous coronary intervention according to clinical, ischemic, and bleeding risks.","volume":"82","author":"Yang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250416","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1755-5922.12237","article-title":"Extended dual antiplatelet therapy after acute coronary syndrome in Spain: results from the EPICOR study.","volume":"35","author":"Bardaj\u00ed","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"R7-20250416","doi-asserted-by":"crossref","first-page":"e0209661","DOI":"10.1371\/journal.pone.0209661","article-title":"Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease.","volume":"14","author":"Witberg","year":"2019","journal-title":"PLoS One"},{"key":"R8-20250416","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1111\/bcp.14833","article-title":"Drug-drug interactions with warfarin: a systematic review and meta-analysis.","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R9-20250416","doi-asserted-by":"crossref","first-page":"230","DOI":"10.31083\/j.rcm2408230","article-title":"The efficacy and safety of proton pump inhibitors combining dual antiplatelet therapy in patients with coronary intervention: a systematic review, meta-analysis and trial sequential analysis of randomized controlled trials.","volume":"24","author":"Liang","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"R10-20250416","article-title":"Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: a systematic review and meta-analysis.","volume":"13","author":"Luo","year":"2022","journal-title":"Front Pharmacol"},{"key":"R11-20250416","doi-asserted-by":"crossref","first-page":"107802","DOI":"10.1016\/j.clineuro.2023.107802","article-title":"Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy.","volume":"231","author":"Huang","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"R12-20250416","first-page":"e21885","article-title":"Co-prescription of dual-antiplatelet therapy and proton pump inhibitors: current guidelines.","volume":"14","author":"Saven","year":"2022","journal-title":"Cureus"},{"key":"R13-20250416","doi-asserted-by":"crossref","first-page":"107325","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107325","article-title":"Neutrophil-to-lymphocyte ratio at admission is a risk factor for in-hospital gastrointestinal bleeding in acute ischemic stroke patients after dual antiplatelet therapy: a case control study.","volume":"32","author":"Huang","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R14-20250416","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12928-021-00833-z","article-title":"Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals.","volume":"37","author":"Yokoi","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"R15-20250416","doi-asserted-by":"crossref","first-page":"e000248","DOI":"10.1136\/openhrt-2015-000248","article-title":"Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis.","volume":"2","author":"Cardoso","year":"2015","journal-title":"Open Heart"},{"key":"R16-20250416","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/00365521.2021.1906945","article-title":"Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention.","volume":"56","author":"Sveinsdottir","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"R17-20250416","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines.","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"R18-20250416","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis.","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"R19-20250416","doi-asserted-by":"crossref","first-page":"e007230","DOI":"10.1136\/bmjopen-2014-007230","article-title":"Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.","volume":"5","author":"Campbell","year":"2015","journal-title":"BMJ Open"},{"key":"R20-20250416","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-230X-14-130","article-title":"Risk score to predict gastrointestinal bleeding after acute ischemic stroke.","volume":"14","author":"Ji","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"R21-20250416","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14740338.2018.1524869","article-title":"Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease.","volume":"17","author":"Romano","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"R22-20250416","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14740338.2023.2245331","article-title":"Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes.","volume":"22","author":"Occhipinti","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"R23-20250416","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jwh.2010.2097","article-title":"The association of adverse pregnancy events and cardiovascular disease in women 50 years of age and older.","volume":"20","author":"Freibert","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"R24-20250416","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gutjnl-2020-321585","article-title":"Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial.","volume":"70","author":"Mahady","year":"2021","journal-title":"Gut"},{"key":"R25-20250416","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cjca.2015.05.012","article-title":"The Effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF Study.","volume":"32","author":"Lefebvre","year":"2016","journal-title":"Can J Cardiol"},{"key":"R26-20250416","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/bimj.201800252","article-title":"The population-attributable fraction for time-dependent exposures using dynamic prediction and landmarking.","volume":"62","author":"von Cube","year":"2020","journal-title":"Biom J"},{"key":"R27-20250416","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/bimj.202000085","article-title":"A flexible joint model for multiple longitudinal biomarkers and a time-to-event outcome: with applications to dynamic prediction using highly correlated biomarkers.","volume":"63","author":"Li","year":"2021","journal-title":"Biom J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:01:07Z","timestamp":1744804867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041935","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}